Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807763 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL6257271 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL3237794 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL9807794 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL10071610 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL4755851 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL9567939 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL11043940 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| SCHEMBL7167469 | 1.00 | TSHR (0.48) | TSHRDNM1ALDH1A1KCNH2FAAH | |
| Hydrochloric Acid SCHEMBL5267014 | 0.98 | DNM1 (0.46) | TSHRDNM1ALDH1A1KCNH2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019115654-A1 | PROCESS FOR THE PRODUCTION OF PERFLUORINATED ALKYLVINYLETHERS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2019-06-20 | — | — | WO | claimed |
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-26 | — | — | US | claimed |
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | claimed |
| CN-117043136-A | Fluorine-based ionic liquid and method for producing same | 第一工业制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2019115654-A1 | PROCESS FOR THE PRODUCTION OF PERFLUORINATED ALKYLVINYLETHERS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2019-06-20 | — | — | WO | disclosed |
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-26 | — | — | US | disclosed |
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20090035696-A1 | PHOTORESIST COMPOSITION | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-6361801-B1 | HAIR FIXING ALLYL POLYMER | CALGON CORPORATION | 2002-03-26 | — | — | US | disclosed |
| WO-2000005192-A2 | ALKYL ALLYL AMINES AND LOW VOC HAIR STYLING COMPOSITIONS USING SAME | CALGON CORPORATION (US) | 2000-02-03 | — | — | WO | disclosed |
| EP-0430054-A1 | Highly adhesive synthetic fiber material | TEIJIN LIMITED (JP) | 1991-06-05 | — | — | EP | disclosed |
| EP-0142337-B1 | METHOD FOR IMPROVING COLOR FASTNESS | NITTO BOSEKI CO., LTD. (JP) | 1987-08-12 | — | — | EP | disclosed |
| EP-0196588-A2 | Process for the preparation of copolymers of N-substituted secondary monoallylamines or salts thereof | NITTO BOSEKI CO., LTD. (JP) | 1986-10-08 | — | — | EP | disclosed |
| US-4583989-A | TREATING DYED PRODUCT WITH AQUEOUS SOLUTION OF ALLYLAMINE COPOLYMER | NITTO BOSEKI CO., LTD. (DE) | 1986-04-22 | — | — | US | disclosed |
| EP-0142337-A1 | Method for improving color fastness | NITTO BOSEKI CO., LTD. (JP) | 1985-05-22 | — | — | EP | disclosed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | disclosed |
| US-4348380-A | CYCLOPOLYMERIZED SALT OF ALKYL DIALLYLAMINE | L'OREAL (FR) | 1982-09-07 | — | — | US | disclosed |
| US-4287172-A | POLYMERS OF DIALLYLAMMONIUM SALTS | L'OREAL (FR) | 1981-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | DOT1L, EHMT2, CDH1 | TSHR 4580/4885DNM1 4319/4885ALDH1A1 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.